Ara
Toplam kayıt 3, listelenen: 1-3
Suboptimal use of non-vitamin K antagonist oral anticoagulants: Results from the RAMSES study
(Lippincott Williams & Wilkins, 2016)
This study aimed to investigate the potential misuse of novel oral anticoagulants (NOACs) and the physicians' adherence to current European guideline recommendations in real-world using a large dataset from Real-life ...
Guideline-adherent therapy for stroke prevention in atrial fibrillation in different health care settings: Results from ramses study
(Elsevier B.V., 2017)
Objective No studies have been conducted in Turkey to compare the quality of stroke prevention therapies provided in different healthcare settings in patients with atrial fibrillation (AF). Therefore, we aimed to evaluate ...
Hemopericardium and cardiac tamponade in a patient treated with dabigatran etexilate
(Korean Soc Cardiology, 2016)
Dabigatran etexilate is one of the new oral anticoagulants approved to reduce the risk of stroke in patients with atrial fibrillation (AF). A variety of bleeding complications with dabigatran have been reported, but reports ...